{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ultra-Long-Acting Insulins: A Review of Efficacy,Safety, and Implications for Practice
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the clinical properties, dosing, packaging and place in therapy of ultralong acting insulins.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe the pharmacodynamics of insulin glargine U100, U300, and insulin degludec.
- Describe the benefits of long acting insulins in clinical practice.
- Determine proper dosing of long acting insulins in clinical practice.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- AANP 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
This Activity is approved for 1.5 contact hour (s) of continuing education (which includes 1.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 18033125.
This Activity was planned in accordance with AANP Accreditation Standards and Policies.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JAANP0718
Published: Jul 2018
Expires: 1/1/2026
Required Passing Score: 13/18 (72%)